# Ustekinumab Real World Evidence Study

> **NCT07748338** · — · COMPLETED · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 601 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Ustekinumab

## Key facts

- **NCT ID:** NCT07748338
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-30
- **Primary completion:** 2025-03-20
- **Final completion:** 2025-03-20
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2026-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748338, "Ustekinumab Real World Evidence Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*